BWXT Medical Submits Tc-99m Generator New Drug Application to FDA
13 September 2022
Company Highlights Growing Nuclear Medicine Product Portfolio and Future Opportunities in Therapeutic Radioisotopes
Warning: Javascript must be enabled within your browser's settings for this site to function properly.
Your browser appears to be out of date, and is not supported by this site. For the best experience, we recommend that you upgrade to a more modern browser. You can find a list of modern browsers from www.browsehappy.com.
We use technical and analytics cookies data to ensure that we give you the best experience on our website. For more information visit our Privacy Page.
Company Highlights Growing Nuclear Medicine Product Portfolio and Future Opportunities in Therapeutic Radioisotopes